Company News
A New Era of Cell Analysis: AI-Powered Label-Free Flow Cytometry Launches in China.
The VisionSort flow cytometer, the first of its kind to use real-time AI for label-free cell sorting, was unveiled at the 16th Annual Conference for China Immunology Society. This groundbreaking technology is set to revolutionize cell analysis research.
In-depth Conversation with Academician Wu Yuzhang: Research and Clinical Application Prospects of Artificial Intelligence Cell Analysis Technology
October 25, 2024
The rapid advancement of AI, exemplified by the success of ChatGPT and recent Nobel Prizes, is transforming life sciences. ThinkCyte, a pioneer in AI-powered cell analysis, has launched the VisionSort flow cytometer in China, offering a new tool for researchers. This innovative technology, which requires no fluorescent labeling, was unveiled 16th Annual Conference for China Immunology Society in Hangzhou.
ThinkCyte and BJH Biotech Partner towards a New Era of AI in Flow Cytometry in China
ThinkCyte and BJH Biotech have formed a strategic partnership to bring AI-powered flow cytometry technology to China. The two parties will carry out extensive business cooperation on ThinkCyte's unique AI label-free ghost cytometry technology products and services nationwide. BJH Biotech will serve as ThinkCyte's exclusive distributor and strategic partner in the Chinese region (excluding Hong Kong, Macau, and Taiwan) for research users, dedicated to popularizing the application of ghost cytometry in the fields of life sciences and biomedicine in China.
A Glimpse to the Innovation Waves of Flow Cytometry Technologies from CYTO2024
May 24, 2024
Edinburgh, a Scottish city renowned for its pursuit of freedom, hosted the 37th International Congress of Cytometry, CYTO2024, in early May. With over 3,000 attendees and 80+ exhibitors gathering at the Edinburgh International Conference Centre, the city experienced a significant surge in popularity. Held annually, the CYTO conference is a yearly reunion for all professionals in the flow cytometry industry and serves as a barometer for trends in cell analysis technology."
